Off-Label Uses of Caverject (Alprostadil)

What Caverject Is and How It Works

Caverject is an injectable form of alprostadil, a synthetic version of prostaglandin E1 (PGE1). When injected directly into penile tissue, it relaxes smooth muscle and dilates blood vessels, allowing increased blood flow that may produce an erection. The FDA approved Caverject for the treatment of erectile dysfunction in adult men; its indication is not restricted to patients who have failed other treatments.

Alprostadil's mechanism, however, is not limited to penile tissue. Prostaglandin E1 receptors are found throughout the vascular system, which is why researchers and clinicians have explored its potential in conditions where improving circulation is the therapeutic goal. This broad vasodilatory action is the foundation for most of its off-label applications.

Penile Rehabilitation After Prostate Surgery

One of the most widely discussed off-label uses of Caverject is penile rehabilitation following radical prostatectomy, the surgical removal of the prostate gland for cancer treatment. Nerve damage during surgery often results in temporary or permanent erectile dysfunction. Early and regular use of alprostadil injections after surgery is thought to maintain oxygenation of penile smooth muscle tissue, possibly reducing fibrosis and supporting long-term erectile recovery.

Some urologists begin rehabilitation programs within weeks of surgery, using low-dose injections several times per week. While study results vary, several clinical series suggest that men who participate in structured rehabilitation programs may have better outcomes than those who wait for spontaneous return of function. A urologist familiar with post-prostatectomy care should design and monitor any such program.

Vascular Applications Beyond Sexual Health

Alprostadil has been studied and used in vascular medicine for decades, particularly in Europe, where intravenous formulations have been available longer than in the United States.

Critical limb ischemia (CLI) is a severe form of peripheral artery disease in which blood flow to the legs or feet is critically reduced, causing rest pain, ulcers, or gangrene. In patients who are not candidates for surgical or interventional revascularization, intravenous alprostadil may be used off-label to improve microcirculation, reduce pain, and potentially promote wound healing. Intravenous prostanoids have been studied in patients with chronic limb-threatening ischemia who have no revascularization option, but evidence for alprostadil is limited and uncertain; they are not a substitute for urgent vascular assessment or revascularization when feasible.

Raynaud's phenomenon involves episodic vasospasm of the fingers and toes, typically triggered by cold or stress. For severe systemic-sclerosis–associated Raynaud phenomenon or digital ischemia that does not respond to oral therapy, specialists may consider intravenous prostanoids. Evidence and availability differ among agents; intravenous iloprost has substantially greater guideline support than alprostadil in many settings. This application is generally reserved for patients whose symptoms have not responded to standard oral vasodilators.

Diagnostic and Procedural Uses

Alprostadil also plays a role in certain diagnostic and procedural settings that fall outside its approved indication.

In penile Doppler ultrasonography, a small dose of alprostadil is injected to induce an erection, allowing clinicians to assess arterial blood flow and diagnose the underlying cause of erectile dysfunction, whether arterial, venous, or neurogenic. Caverject is also FDA-approved as an adjunct to diagnostic testing for erectile dysfunction. Whether a particular penile Doppler protocol falls within the label depends on how the product is used.

A Related Use of Alprostadil

Outside diagnostic settings, a different intravenous formulation of alprostadil is used in neonatal cardiology to keep the ductus arteriosus open in infants with certain congenital heart defects. This separate product and patient population illustrate the broader medical use of prostaglandin E1 beyond Caverject.

Comparing Approved vs. Off-Label Alprostadil Uses

Understanding where Caverject fits within the broader landscape of alprostadil therapy can help patients ask better questions of their clinicians.

This table highlights that while Caverject itself has a narrow approval, alprostadil as a compound is trusted across multiple medical disciplines, and the science behind each application is grounded in the same core mechanism.

Safety Considerations and Monitoring

Off-label use of any medication requires a thoughtful risk-benefit conversation between patient and provider. With Caverject and alprostadil more broadly, several safety considerations deserve attention.

Priapism, a prolonged erection lasting more than four hours, is the most serious risk associated with intracavernosal injection and requires prompt medical attention to prevent permanent tissue damage. Patients using alprostadil at home for ED or penile rehabilitation should know exactly when and how to seek emergency care.

For vascular applications given intravenously, hypotension (low blood pressure) is a key concern, particularly in older adults or those with cardiovascular disease. Intravenous infusions are typically administered in monitored settings for this reason.

Injection site reactions, including pain, bruising, and, with long-term use, fibrosis or scarring of penile tissue, are also possible. Rotating injection sites and following proper technique can reduce these risks.

Doctronic's AI platform, which has achieved 99.2% treatment plan alignment with board-certified physicians across more than 22 million consultations, can help patients understand medication risks and prepare informed questions before visiting a specialist. Affordable $39 video visits are available around the clock for those who want to speak directly with a clinician.

Frequently Asked Questions

What does 'off-label' mean when a doctor prescribes Caverject?

Off-label means a medication is prescribed for a purpose not listed in its FDA approval. This is legal and common. Doctors use clinical evidence and professional judgment to determine whether an off-label use may benefit a specific patient, always weighing potential risks against expected outcomes.

Can Caverject be used for penile rehabilitation after prostate cancer surgery?

Yes, penile rehabilitation is one of the more studied off-label uses of alprostadil. Regular injections after radical prostatectomy may help preserve erectile tissue oxygenation, potentially improving long-term sexual function recovery. A urologist typically supervises this protocol and adjusts dosing based on individual response.

Is alprostadil used for conditions outside of sexual health?

Yes. Alprostadil's vasodilating properties make it useful in vascular medicine. Off-label applications include treating critical limb ischemia and Raynaud's phenomenon, where improved blood flow to affected tissues is the goal. These uses are typically managed by vascular specialists in clinical or hospital settings.

What are the main risks of off-label Caverject use?

Common risks include pain at the injection site, prolonged erection (priapism), low blood pressure, and dizziness. Systemic administration for vascular conditions carries additional cardiovascular monitoring requirements. Any concerning symptoms after use should be reported to a clinician promptly, as some complications require urgent care.

How can Doctronic help me learn more about alprostadil?

Doctronic, the first AI legally authorized to practice medicine in Utah, offers free AI consultations and $39 video visits available 24/7. You can discuss your medication questions, symptoms, or treatment options with an AI or board-certified physician anytime, from anywhere, in a HIPAA-aligned environment.

The Bottom Line

Caverject (alprostadil) is primarily known for treating erectile dysfunction, but its powerful vasodilating effects have made it a candidate for several off-label applications including penile rehabilitation, critical limb ischemia, and Raynaud's phenomenon. These uses carry meaningful risks and require close medical supervision. Patients curious about whether alprostadil might help their condition should speak with a qualified clinician before making any changes. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.